Glycemic efficacy refers to the capacity of regulated glycemic levels to produce an effect in people with diabetes and heart disease. [1] According to Zeev Vlodaver, Robert F. Wilson and Daniel J. Garry, " exenatide and liraglutide are synthetic GLP-1 agonists and have demonstrated glycemic efficacy (HbA1c reductions of between 0.7 and 2%) associated with mild weight loss." [2] Glyburide, metformin and rosiglitazone have been assessed as a monotherapy in the durability of glycemic efficacy. [3]
Glycemic efficacy refers to the capacity of regulated glycemic levels to produce an effect in people with diabetes and heart disease. [1] According to Zeev Vlodaver, Robert F. Wilson and Daniel J. Garry, " exenatide and liraglutide are synthetic GLP-1 agonists and have demonstrated glycemic efficacy (HbA1c reductions of between 0.7 and 2%) associated with mild weight loss." [2] Glyburide, metformin and rosiglitazone have been assessed as a monotherapy in the durability of glycemic efficacy. [3]